Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-23-018529

Options or other derivatives

  • CEO and President acquired 939,375 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KLEMP WALTER V CEO and President 2023-06-22 Grant or award · Stock option (right to buy) +400,000 1,416,691 D
KLEMP WALTER V CEO and President 2023-06-22 Grant or award · Restricted Stock Units +539,375 1,956,066 D
Loading xslF345X04/rdgdoc.xml…